Advertisement feature for antimicrobial IPS
hygiene performance – far beyond surface-level solutions. This dedication to innovation and integrity fuels our mission to raise the standards of interior healthcare environments worldwide.
Key benefits of antimicrobial 1 Reduces the risk of cross-contamination: Antimicrobial materials are engineered to actively inhibit the growth of harmful microorganisms such as bacteria, fungi, and some viruses. This helps break the chain of infections, especially in clinical environments where surfaces are frequently touched. 2 Provides continuous protection: Unlike traditional disinfectants, antimicrobial surfaces offer round-the-clock protection. Once infused into materials like PVC cladding or IPS units, the antimicrobial agents work continuously, offering an added layer of defence between cleaning cycles. 3 Supports infection control compliance: Hospitals and clinical environments are under strict regulatory requirements to minimise healthcare-associated infections (HCAIs). Installing antimicrobial solutions helps meet these compliance goals more effectively and consistently. 4 Improves surface hygiene with minimal maintenance: Antimicrobial surfaces help reduce microbial load, which in turn lowers the need for aggressive chemical cleaning and frequent sanitisation. This not only saves time and cost, but also reduces wear on interior materials. 5 Enhances patient and staff safety: By reducing the presence of harmful microorganisms, antimicrobial systems contribute directly to a safer environment, improving patient outcomes, and protecting staff from occupational exposure.
6 Long-lasting efficacy: Unlike surface treatments that degrade over time, embedded antimicrobial technologies are engineered to remain effective for the lifespan of the product – making them a sustainable, long-term investment in hygiene. 7 Ideal for high-risk and high-touch environments: From operating theatres to laboratories, and school washrooms to fitness centers, antimicrobial surfaces provide a practical solution wherever hygiene is critical.
At Bioclad we are extremely passionate about our products being safe and long-lasting. After doing intensive testing with our IPS units, and developing the unit to meet the highest standards of durability, infection control, and user-friendly installation, we’re proud to offer a solution that performs in the most demanding healthcare environments.
Looking ahead, the future for Bioclad is filled with continued innovation and exciting new developments. Building on the success of our patented antimicrobial IPS units, we are expanding our product range with new colorways to offer greater design flexibility without compromising on hygiene. We are also enhancing our existing printed design sheet offering, with a new range set to launch that brings even more creative and bespoke options to our clients – perfect for environments where both visual impact and hygiene are key, such as children’s wards, mental health facilities, and educational spaces. As we continue to grow, our mission remains the same: to deliver world-class hygienic solutions that improve the environment and protect lives.
displays the test results, with only the BioClad®
sample treated with BioCote®
technology demonstrating strong antibacterial performance after ageing. In this test, a result listed as “GROWTH” means bacteria continued to multiply on the sample after 24 hours of contact.
Key Findings • BioClad® E. coli.
Treated – 98.80% reduction against MRSA, 99.88% against
• Competitor 2 – 40.93% reduction against MRSA, but bacterial growth observed for E. coli.
• Competitor 4 – 83.71% reduction against MRSA, but bacterial growth observed for E. coli. • All other competitors – Bacterial growth observed for both MRSA and E. coli.
These results suggest that many competitor products may rely on the short-term antibacterial effect of unaged PVC, while BioClad®
technology continues to perform even after VOCs have dissipated – demonstrating long-lasting antibacterial protection.
with BioCote®
Competitor Sample ID
Bioclad Bioclad 1 2 3 4 5 6 240/246 240/253 240/247 240/248 240/249 240/250 240/251 240/252
Product Details
PVC CLADDING UNTREATED
PVC CLADDING
BIOCOTE TREATED PVC CLADDING
AM TREATED PVC CLADDING
AM TREATED PVC CLADDING
AM TREATED PVC CLADDING
AM TREATED PVC CLADDING
AM TREATED PVC CLADDING
AM TREATED
Methods Bacteria ISO 22196 MRSA
E. coli
ISO 22196 MRSA E. coli
ISO 22196 MRSA E. coli
ISO 22196 MRSA E. coli
ISO 22196 MRSA E. coli
ISO 22196 MRSA E. coli
ISO 22196 MRSA E. coli
ISO 22196 MRSA E. coli
Test
Test
Against Initial GROWTH
GROWTH 98.80%
99.88%
GROWTH GROWTH
40.93%
GROWTH GROWTH
GROWTH 83.71%
GROWTH GROWTH
GROWTH GROWTH
GROWTH Table 1. Third-party laboratory antimicrobial efficacy testing results.
Reduction
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
